 SUWANEE, GA, April 02, 2020 GLOBE NEWSWIRE -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. SNWV and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronixs surface acoustic wave ultrasound technology in the wound care market. Under this agreement, SANUWAVE has acquired the exclusive worldwide license and sales rights for NanoVibronixs patch-based therapeutic ultrasound technology device, WoundShield, that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. SANUWAVE will seek regulatory approval of WoundShield in Europe and the United States and NanoVibronix shall maintain the sole right to manufacture the licensed products. 